Yet we sit at .50. Does the market not trust the

Quote:

---

Yet we sit at .50. Does the market not trust the PR on TNBC?

---

It seems, especially on the OTC, that traders just don’t care about the science. It’s all about the financing and that’s all they see here with Cytodyn. RTB is a good illustration of that. He never posts about the science, only the cash. The other downside of the OTC is traders assume by default that PRs are exaggerated or fluff.

Here, that will all change very soon.